Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Treatment Outcome.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
7.820
Treatment Outcome
  1. Incremental hemodialysis transition in veterans and nonveterans with kidney failure. Curr Opin Nephrol Hypertens. 2025 Jan 01; 34(1):33-40.
    View in: PubMed
    Score: 0.201
  2. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial. BMJ Open. 2021 05 24; 11(5):e047596.
    View in: PubMed
    Score: 0.158
  3. Comparing Patient Survival of Home Hemodialysis and Peritoneal Dialysis Patients. Am J Nephrol. 2020; 51(3):192-200.
    View in: PubMed
    Score: 0.144
  4. Acute kidney injury following coronary revascularization procedures in patients with advanced CKD. Nephrol Dial Transplant. 2019 11 01; 34(11):1894-1901.
    View in: PubMed
    Score: 0.142
  5. Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. Atherosclerosis. 2019 11; 290:59-65.
    View in: PubMed
    Score: 0.141
  6. One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. J Ren Nutr. 2019 09; 29(5):428-437.
    View in: PubMed
    Score: 0.134
  7. Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis. J Ren Nutr. 2019 03; 29(2):82-90.
    View in: PubMed
    Score: 0.133
  8. No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time. Am J Nephrol. 2018; 48(5):389-398.
    View in: PubMed
    Score: 0.133
  9. Predialysis coronary revascularization and postdialysis mortality. J Thorac Cardiovasc Surg. 2019 03; 157(3):976-983.e7.
    View in: PubMed
    Score: 0.131
  10. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Am J Kidney Dis. 2018 11; 72(5):701-710.
    View in: PubMed
    Score: 0.130
  11. Dialysis Provider and Outcomes among United States Veterans Who Transition to Dialysis. Clin J Am Soc Nephrol. 2018 07 06; 13(7):1055-1062.
    View in: PubMed
    Score: 0.129
  12. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. Am J Nephrol. 2018; 47(5):333-342.
    View in: PubMed
    Score: 0.128
  13. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int. 2018 05; 93(5):1207-1216.
    View in: PubMed
    Score: 0.126
  14. Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients. Nephron. 2018; 139(1):13-22.
    View in: PubMed
    Score: 0.125
  15. There's no place like home: 35-year patient survival on home hemodialysis. Semin Dial. 2018 05; 31(3):300-304.
    View in: PubMed
    Score: 0.124
  16. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients. Am J Kidney Dis. 2018 06; 71(6):802-813.
    View in: PubMed
    Score: 0.124
  17. Predictive Score for Posttransplantation Outcomes. Transplantation. 2017 06; 101(6):1353-1364.
    View in: PubMed
    Score: 0.120
  18. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1109-1117.
    View in: PubMed
    Score: 0.119
  19. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
    View in: PubMed
    Score: 0.119
  20. Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol. 2017 Aug; 30(4):521-529.
    View in: PubMed
    Score: 0.118
  21. Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management. Panminerva Med. 2017 Jun; 59(2):188-196.
    View in: PubMed
    Score: 0.117
  22. Dietary protein intake and chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2017 01; 20(1):77-85.
    View in: PubMed
    Score: 0.116
  23. Racial-ethnic disparities in mortality and kidney transplant outcomes among pediatric dialysis patients. Pediatr Nephrol. 2017 04; 32(4):685-695.
    View in: PubMed
    Score: 0.115
  24. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression. Diabetes Care. 2016 Nov; 39(11):1940-1947.
    View in: PubMed
    Score: 0.112
  25. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
    View in: PubMed
    Score: 0.111
  26. Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States. J Am Soc Nephrol. 2016 07; 27(7):2123-34.
    View in: PubMed
    Score: 0.108
  27. What Is Known and Unknown About Twice-Weekly Hemodialysis. Blood Purif. 2015; 40(4):298-305.
    View in: PubMed
    Score: 0.108
  28. Peritoneal Equilibration Test and Patient Outcomes. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):1990-2001.
    View in: PubMed
    Score: 0.107
  29. Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1179-91.
    View in: PubMed
    Score: 0.104
  30. Association of Height with Mortality in Patients Undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2015 Jun 05; 10(6):965-74.
    View in: PubMed
    Score: 0.103
  31. Is there a role for ketoacid supplements in the management of CKD? Am J Kidney Dis. 2015 May; 65(5):659-73.
    View in: PubMed
    Score: 0.102
  32. Outcomes of cephalic arch stenosis with and without stent placement after percutaneous balloon angioplasty in hemodialysis patients. Semin Dial. 2015 Jan-Feb; 28(1):E7-E10.
    View in: PubMed
    Score: 0.100
  33. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis. 2014 Aug; 64(2):181-6.
    View in: PubMed
    Score: 0.097
  34. Balancing nutrition and serum phosphorus in maintenance dialysis. Am J Kidney Dis. 2014 Jul; 64(1):143-50.
    View in: PubMed
    Score: 0.096
  35. Updates on the management of diabetes in dialysis patients. Semin Dial. 2014 Mar; 27(2):135-45.
    View in: PubMed
    Score: 0.096
  36. Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol. 2014; 39(3):183-94.
    View in: PubMed
    Score: 0.095
  37. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48.
    View in: PubMed
    Score: 0.095
  38. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial. 2013 Nov-Dec; 26(6):720-7.
    View in: PubMed
    Score: 0.093
  39. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013; 38(2):136-48.
    View in: PubMed
    Score: 0.092
  40. Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes. Clin J Am Soc Nephrol. 2012 Nov; 7(11):1859-71.
    View in: PubMed
    Score: 0.086
  41. Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens. 2012 Jul; 21(4):389-403.
    View in: PubMed
    Score: 0.085
  42. Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes. Nephrol Dial Transplant. 2012 Aug; 27(8):3345-51.
    View in: PubMed
    Score: 0.084
  43. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis. 2012 Jun; 59(6):841-8.
    View in: PubMed
    Score: 0.083
  44. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol. 2012 Feb; 7(2):332-41.
    View in: PubMed
    Score: 0.082
  45. Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients. Diabetes Care. 2011 Dec; 34(12):2536-41.
    View in: PubMed
    Score: 0.081
  46. Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2712-21.
    View in: PubMed
    Score: 0.081
  47. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1973-81.
    View in: PubMed
    Score: 0.080
  48. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol. 2011 May 31; 7(7):369-84.
    View in: PubMed
    Score: 0.079
  49. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant. 2011 May; 11(5):1006-15.
    View in: PubMed
    Score: 0.078
  50. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol. 2011 Jun; 6(6):1463-73.
    View in: PubMed
    Score: 0.078
  51. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):842-51.
    View in: PubMed
    Score: 0.075
  52. Epidemiology of dietary nutrient intake in ESRD. Semin Dial. 2010 Jul-Aug; 23(4):353-8.
    View in: PubMed
    Score: 0.074
  53. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol. 2010; 31(5):419-25.
    View in: PubMed
    Score: 0.073
  54. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010 Mar; 5(3):519-30.
    View in: PubMed
    Score: 0.072
  55. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Sep; 4(9):1529-39.
    View in: PubMed
    Score: 0.070
  56. Severity of hypoalbuminemia predicts response to intradialytic parenteral nutrition in hemodialysis patients. J Ren Nutr. 2009 Jul; 19(4):291-7.
    View in: PubMed
    Score: 0.069
  57. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am J Kidney Dis. 2009 Aug; 54(2):289-98.
    View in: PubMed
    Score: 0.068
  58. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis. 2009 May; 53(5):823-34.
    View in: PubMed
    Score: 0.068
  59. Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009 Mar; 4(3):673-9.
    View in: PubMed
    Score: 0.068
  60. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis. 2009 Mar; 16(2):143-51.
    View in: PubMed
    Score: 0.068
  61. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008 Dec; 88(6):1511-8.
    View in: PubMed
    Score: 0.066
  62. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1769-76.
    View in: PubMed
    Score: 0.065
  63. Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease. Expert Opin Investig Drugs. 2008 Apr; 17(4):451-67.
    View in: PubMed
    Score: 0.063
  64. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring). 2008 Feb; 16(2):442-50.
    View in: PubMed
    Score: 0.063
  65. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol. 2008; 28(2):275-9.
    View in: PubMed
    Score: 0.062
  66. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol. 2007 Nov; 2(6):1317-28.
    View in: PubMed
    Score: 0.062
  67. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int. 2007 Nov; 72(9):1149-56.
    View in: PubMed
    Score: 0.061
  68. Hepatitis C infection in dialysis patients: a link to poor clinical outcome? Int Urol Nephrol. 2007; 39(1):247-59.
    View in: PubMed
    Score: 0.057
  69. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004 Aug; 80(2):299-307.
    View in: PubMed
    Score: 0.049
  70. Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes. Toxins (Basel). 2024 Jun 28; 16(7).
    View in: PubMed
    Score: 0.049
  71. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol. 2004 Feb; 15(2):442-53.
    View in: PubMed
    Score: 0.048
  72. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003 Jan; 13(1):15-25.
    View in: PubMed
    Score: 0.044
  73. REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients. Nutrition. 2023 03; 107:111899.
    View in: PubMed
    Score: 0.044
  74. Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovasc Diabetol. 2021 06 22; 20(1):125.
    View in: PubMed
    Score: 0.040
  75. Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study. Cardiovasc Diabetol. 2021 01 07; 20(1):13.
    View in: PubMed
    Score: 0.038
  76. Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation. Curr Opin Nephrol Hypertens. 2021 01; 30(1):14-26.
    View in: PubMed
    Score: 0.038
  77. Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs. 2020 Sep; 80(13):1267-1292.
    View in: PubMed
    Score: 0.038
  78. Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients. Nephron. 2020; 144(7):321-330.
    View in: PubMed
    Score: 0.037
  79. Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):342-350.
    View in: PubMed
    Score: 0.036
  80. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
    View in: PubMed
    Score: 0.035
  81. Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes. J Am Heart Assoc. 2019 03 19; 8(6):e011869.
    View in: PubMed
    Score: 0.034
  82. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial. J Intern Med. 2018 03; 283(3):314-327.
    View in: PubMed
    Score: 0.031
  83. Warfarin Use and Increased Mortality in End-Stage Renal Disease. Am J Nephrol. 2017; 46(4):249-256.
    View in: PubMed
    Score: 0.031
  84. Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Aug 07; 12(8):1274-1283.
    View in: PubMed
    Score: 0.030
  85. Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes. Am J Nephrol. 2017; 45(5):431-441.
    View in: PubMed
    Score: 0.030
  86. Incremental Hemodialysis: The University of California Irvine Experience. Semin Dial. 2017 05; 30(3):262-269.
    View in: PubMed
    Score: 0.030
  87. Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis. Clin J Am Soc Nephrol. 2016 Feb 05; 11(2):298-307.
    View in: PubMed
    Score: 0.027
  88. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32.
    View in: PubMed
    Score: 0.026
  89. The relationship between ultraviolet light exposure and mortality in dialysis patients. Am J Nephrol. 2014; 40(3):224-32.
    View in: PubMed
    Score: 0.025
  90. Using a web-based nutrition algorithm in hemodialysis patients. J Ren Nutr. 2015 Jan; 25(1):6-16.
    View in: PubMed
    Score: 0.025
  91. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014 Mar; 63(3):456-63.
    View in: PubMed
    Score: 0.024
  92. Renal Transplant Outcomes in Waitlist Candidates with a Previous Inactive Status Due to Being Temporarily Too Sick. Clin Transpl. 2014; 117-24.
    View in: PubMed
    Score: 0.024
  93. Bone and mineral disorders after kidney transplantation: therapeutic strategies. Transplant Rev (Orlando). 2014 Apr; 28(2):56-62.
    View in: PubMed
    Score: 0.024
  94. PD First: peritoneal dialysis as the default transition to dialysis therapy. Semin Dial. 2013 Nov-Dec; 26(6):706-13.
    View in: PubMed
    Score: 0.023
  95. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013 Dec; 84(6):1096-107.
    View in: PubMed
    Score: 0.023
  96. Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013 Mar; 8(3):460-7.
    View in: PubMed
    Score: 0.022
  97. Roma ethnicity and clinical outcomes in kidney transplant recipients. Int Urol Nephrol. 2012 Jun; 44(3):945-54.
    View in: PubMed
    Score: 0.020
  98. Peritoneal dialysis: an underutilized modality. Curr Opin Nephrol Hypertens. 2010 Nov; 19(6):573-7.
    View in: PubMed
    Score: 0.019
  99. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011 Jan 24; 171(2):110-8.
    View in: PubMed
    Score: 0.019
  100. Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol. 2010 Jul; 74(1):12-8.
    View in: PubMed
    Score: 0.019
  101. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int. 2009 Jul; 76(1):97-107.
    View in: PubMed
    Score: 0.017
  102. Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008 Jan-Feb; 14(1):18-27.
    View in: PubMed
    Score: 0.016
  103. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol. 2007 Oct; 18(10):2781-8.
    View in: PubMed
    Score: 0.015
  104. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant. 2007 Jan; 22(1):209-17.
    View in: PubMed
    Score: 0.014
  105. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr. 2005 Jul; 15(3):345-55.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.